PhytoMedical study shows beneficial effects of cinnamon in treatment of inflammatory disease

By Lisa Kerner

Erie, Pa., April 18 - PhytoMedical Technologies, Inc. said a study presented at Experimental Biology 2006 provided further new evidence of the beneficial effects of compounds in cinnamon that improve insulin function, lower blood sugar levels and triglycerides (fatty acids in blood) and also act as anti-inflammatory agents, which may be useful in the treatment of arthritis, allergies and inflammatory diseases.

"The study provides new biochemical evidence for the beneficial effects of cinnamon in potentiating insulin action and suggests anti-inflammatory properties for the antioxidants in cinnamon," collaborating scientist Heping Cao said in a news release.

In the study, certain bioactive compounds in cinnamon increase the amount of three critically important proteins involved in the body's insulin signaling, glucose transport and inflammatory responses.

PhytoMedical said it is working in collaboration on synthesizing the bio-active components found in cinnamon bark that increase insulin sensitivity. The company plans to produce a safe, synthetic compound that can be taken as a pill or added to liquids.

Cinnamon is not water soluble and contains certain harmful substances that may be toxic if ingested in large amounts over long periods of time.

PhytoMedical, a Princeton, N.J., biopharmaceutical company, is focused on the identification, acquisition, development and commercialization of innovative plant-derived pharmaceutical and nutraceutical compounds targeting cachexia, obesity and diabetes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.